home All News open_in_new Full Article

Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference

TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) — Telo Genomics Corp. (TSXV: TELO; OTCQB: TDSGF) (the “Company” or “Telo”) a leader in the development of diagnostic and prognostic tests for human disease through the analysis of telomeres, today announced that it will present at the OTCQB Venture Virtual Investor Conference on August 7th, 2025. This will […]


today 9 d. ago attach_file Culture

attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture


ID: 3485214560
Add Watch Country

arrow_drop_down